Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
about
Atherosclerosis and infection: is the jury still not in?Risk factors in coronary atherosclerosis athero-inflammation: the meeting pointImmunity, atherosclerosis and cardiovascular diseaseMacrolide antibiotics and the risk of cardiac arrhythmiasToothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey.Cell wall-deficient bacteria as a cause of infections: a review of the clinical significance.Helicobacter pylori infection and eye diseases: a systematic review.Characterization of biofilm formed by human-derived nanoparticlesThe role of infection in the pathogenesis of cardiovascular disease.Fibrinogen: biochemistry, epidemiology and determinants.Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.Helicobacter pylori and extragastric diseases -- other helicobacters.Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.Helicobacter pylori and coronary heart disease: which directions for future studies?Macrolide antibiotics: current and future uses.Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?Intestinal microbiota determine severity of myocardial infarction in rats.Advances in the management of Chlamydia pneumoniae infections.Use of macrolides and tetracyclines for chronic inflammatory diseases.Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.Atherogenesis: the role of inflammation and infection.Chlamydophila pneumoniae infection and cardiovascular diseasePrognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study.Acute respiratory tract infections: a potential trigger for the acute coronary syndrome.A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseasesRelationship between the cytotoxin-associated gene-A status of H pylori strains and cerebral infarction in European Caucasians and Chinese Han: a meta-analysis.Immune mechanisms in atherosclerosis, especially in diabetes type 2Azithromycin-containing versus standard triple therapy for Helicobacter pylori eradication: a meta-analysisUpdate of antibiotic trials for secondary prevention of coronary heart disease.The heart and the gut.Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials.Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases.The effect of different strains of Helicobacter pylori on platelet aggregation.Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes.Periodontitis and atherogenesis: causal association or simple coincidence?Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction.The Impact on Coronary Artery Disease of Common Polymorphisms Known to Modulate Responses to PathogensEffects of Periodontal Therapy on Systemic Markers of Inflammation in Patients With Metabolic Syndrome: A Controlled Clinical Trial
P2860
Q22241306-CF044D92-223F-42A9-8AEB-28D959713974Q24793107-E2F684FC-A8CA-43B7-8A88-C39F6E4B2EF0Q28688590-01F7E693-6AFC-4E42-8621-491360D762ADQ33772270-5600F9AA-C4EA-453D-A341-57AFE355B6FEQ33882323-951C4314-A143-492D-898B-D55312E06CABQ33984369-93DDE7BE-A05A-4E33-8C38-3D2C30344702Q34454857-0C5B9865-F69E-4B9F-88E3-E4F5A24BC481Q34505074-1CBBA6AD-F4E1-4676-BC6C-9F9B40D4DAA7Q35080677-BFE67B69-3BB6-4C55-9268-EDEA1003FAB8Q35538771-F1AE2FEC-FB84-42E4-9BD7-72D8FF2E8621Q35583359-F2DE3640-B95E-4E96-89D8-42C8D58A02AAQ35583594-5A0F99F8-1159-41B4-910D-5385D2E3F8B5Q35583908-7A64ED55-0E35-46D0-B4C3-E1928D0369CCQ35592372-C3A4F48F-2DD0-487F-9877-F661B3318CCEQ35688156-2F921991-877D-41F5-9870-19A752D8E9F7Q35709736-CCEDA271-AB58-45B5-8E0B-66FB96F3CC0AQ35758705-2784342F-0B20-4CFD-8C3C-ADCC29CE2641Q35863790-E9137895-328F-461C-B611-DCEA3F2D16E0Q35917262-243F6286-2AEB-4532-9591-EAE063835DBEQ35962028-D712531A-FA5D-48BA-A74C-AF2EFDFAC587Q36342810-348C8EFE-465C-4D87-9691-27B18D8A9174Q36774193-8E9DBF41-E6F4-4C7A-9723-B35F4465A41BQ36783331-6618654B-34CA-4864-943E-55BF12D6DD88Q37041781-2FD4DC7B-FF45-49B2-99EE-2A20639D4F82Q37091874-28222CB1-39FF-49DA-826D-A9C1A9B5A953Q37098266-329DA0B1-22FE-4669-80CC-58B56BC38051Q37212979-27699F48-065D-4FB0-A116-3C0BF43E69A7Q37261617-0DC9F093-2ED4-4543-946D-EED24D242BD1Q37661005-5B7CB6AB-BC08-4930-8441-9C60E9812D6BQ37865389-78D229C2-92BE-4879-A774-F66E783A93B5Q38122310-D69A7523-B607-49F4-95C4-15DFD1EAED36Q38211000-5A6950FC-8002-4597-AFF2-FBAA92CC097AQ38307119-38D27686-F8D8-4061-888E-1E813E8490D3Q41670405-39F5D545-EBAA-494F-B76F-70CFE0BF9486Q43159895-8E015879-FBA2-426E-9788-683D23220B36Q45194912-57D063BF-4365-457D-A5C1-2BAB3D5B6EC3Q47758018-CB7D0DC0-F192-40AD-B32B-C4117E1D3035Q52609376-5160153A-6C96-4E7A-A859-C88F04770094Q57315909-EAC89CCA-4AA2-41D0-8102-5A06ACE6768EQ58808276-936D8B57-135D-4B82-AE96-AB1E6E78F39B
P2860
Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of treatment for Chlamy ...... and Unstable Angina (STAMINA).
@en
Effect of treatment for Chlamy ...... Infarction and Unstable Angina
@nl
type
label
Effect of treatment for Chlamy ...... and Unstable Angina (STAMINA).
@en
Effect of treatment for Chlamy ...... Infarction and Unstable Angina
@nl
prefLabel
Effect of treatment for Chlamy ...... and Unstable Angina (STAMINA).
@en
Effect of treatment for Chlamy ...... Infarction and Unstable Angina
@nl
P2093
P921
P1433
P1476
Effect of treatment for Chlamy ...... and Unstable Angina (STAMINA).
@en
P2093
A John Camm
Adam F M Stone
Jan Poloniecki
Juan-Carlos Kaski
Michael A Mendall
Paul Risley
Timothy C Northfield
Tracey M Edger
P304
P356
10.1161/01.CIR.0000027820.66786.CF
P407
P577
2002-09-01T00:00:00Z